Mark Arnold Hagler
Chief Commercial Officer · NovaBridge Biosciences
- 2026
- Jul 10, 2026
- 2
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Mark Arnold Hagler files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Sean Wuxiong Cao - $122K in NBP purchases and sales in the last 12 months
- Cong Claire Xu - $20K in NBP purchases and sales in the last 12 months
- Phillip Andrew Dennis - $11K in NBP purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Mark Arnold Hagler?
Mark Arnold Hagler is a corporate insider, tracked as Chief Commercial Officer of NovaBridge Biosciences (NBP). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Mark Arnold Hagler last file a Form 4?
The most recent primary Form 4 on record is dated 10 July 2026, one of 2 filings going back to 2026.
Has Mark Arnold Hagler been buying or selling stock?
Recorded transactions: 1 open-market purchase ($577K) and 0 open-market sales across all tracked filings.
